Genes & Health QMUL KCL costs

Project: Research

Project Details

StatusActive
Effective start/end date18/10/2021 → 17/10/2025

Collaborative partners

  • King's College London (lead)
  • Novo Nordisk A/S
  • Maze Therapeutics, Inc.
  • Merck Sharp & Dohme Corp
  • Bristol-Myers Squibb Company
  • GSK Glaxo Wellcome Research & Development Ltd
  • Takeda Pharmaceuticals International
  • Pfizer Inc.
  • AstraZeneca AB

Funding

  • Queen Mary University of London: £958,231.00